SIRT1 and Hepatic steatosis: These findings suggested that MGF and its metabolite reduce lipogenesis and promote lipolysis through regulating SIRT-1/LKB1/AMPK/SREBP-1 signaling pathways, resulting in alleviation of hepatic steatosis.